GE takes aim at breast tomosynthesis market
August 5, 2013 -- GE Healthcare has long been one of the top two mammography firms, but the company until now hasn't had an offering in the cutting-edge breast tomosynthesis segment. That is changing, however: The firm has begun shipping its SenoClaire tomosynthesis system in Europe and has put the final touches on a regulatory application in the U.S.
Tailored breast screening for younger women finds more cancers
July 31, 2013 -- A tailored breast cancer screening program for women between the ages of 40 and 49 is not only feasible and affordable, it's effective for finding asymptomatic, low-stage tumors, according to a study published in the August issue of Radiology.
Tomosynthesis reduces mammo screening recall rate by 30%
July 30, 2013 -- When added to mammography, digital breast tomosynthesis reduces overall recall rates in breast cancer screening by 30%, with even greater reductions for women younger than 50 and those with dense breasts, according to a new study published online in Radiology.